AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 277 filers reported holding AMICUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $312,576 | +42.6% | 25,600 | +21.9% | 0.00% | +50.0% |
| Q3 2022 | $219,240 | -43.8% | 21,000 | -49.0% | 0.00% | -50.0% |
| Q1 2022 | $390,000 | -17.4% | 41,200 | +0.7% | 0.00% | +33.3% |
| Q4 2021 | $472,000 | +8.5% | 40,900 | -10.1% | 0.00% | -25.0% |
| Q3 2021 | $435,000 | +42.6% | 45,500 | +44.0% | 0.00% | +33.3% |
| Q2 2021 | $305,000 | +33.8% | 31,600 | +36.8% | 0.00% | +50.0% |
| Q1 2021 | $228,000 | -56.3% | 23,100 | +2.2% | 0.00% | -60.0% |
| Q4 2020 | $522,000 | +92.6% | 22,600 | +17.7% | 0.01% | +66.7% |
| Q3 2020 | $271,000 | -10.6% | 19,200 | -4.5% | 0.00% | -25.0% |
| Q2 2020 | $303,000 | – | 20,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |